Whalegun
Home

Matthew T. Wiley, Chief Commercial Officer: BioXcel Therapeutics BTAIQ Sell · Filed 24/10/03

Trade details

Type
Insider sale
Amount
$3,449.6
Shares · price
6,272 sh · $0.55 a share
Held after
19,011 sh
Stock
BioXcel Therapeutics BTAIQ
Person
Matthew T. WileyChief Commercial Officer
Trade date
24/10/03
Filed
24/10/03
Days to filing
0 days

Sold 24.8% of holdings

Share of holding sold
24.8%

BioXcel Therapeutics trades, last 26 weeks

What else happened in BioXcel Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/03~24/11/02

Matthew T. Wiley's recent trades

  • Matthew T. Wiley

    Sell10b5-1 planDefinium Therapeutics

    $113.3K

    Filed 09/29

  • Matthew T. Wiley

    Planned saleDefinium Therapeutics

    $113.8K

    Filed 09/25

  • Matthew T. Wiley

    Sell10b5-1 planDefinium Therapeutics

    $129.1K

    Filed 06/26

  • Matthew T. Wiley

    Planned saleDefinium Therapeutics

    $120.8K

    Filed 06/25

  • Matthew T. Wiley

    Sell10b5-1 planBioXcel Therapeutics

    $148

    Filed 24/09/17